These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26714313)

  • 1. Correction: Percutaneous Coronary Intervention after Fibrinolysis for ST-Segment Elevation Myocardial Infarction Patients: An Updated Systematic Review and Meta-Analysis.
    Liu F; Guo Q; Xie G; Zhang H; Wu Y; Yang L
    PLoS One; 2015; 10(12):e0146207. PubMed ID: 26714313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
    Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
    Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of primary percutaneous coronary intervention and fibrinolytic therapy in ST-segment-elevation myocardial infarction: bayesian hierarchical meta-analyses of randomized controlled trials and observational studies.
    Huynh T; Perron S; O'Loughlin J; Joseph L; Labrecque M; Tu JV; Théroux P
    Circulation; 2009 Jun; 119(24):3101-9. PubMed ID: 19506117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of local delivery of thrombolytics before thrombectomy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (the delivery of thrombolytics before thrombectomy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention [DISSOLUTION] randomized trial).
    Greco C; Pelliccia F; Tanzilli G; Tinti MD; Salenzi P; Cicerchia C; Schiariti M; Franzoni F; Speziale G; Gallo P; Gaudio C
    Am J Cardiol; 2013 Sep; 112(5):630-5. PubMed ID: 23711809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year survival in patients with ST-segment-elevation myocardial infarction according to modalities of reperfusion therapy: the French Registry on Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) 2005 Cohort.
    Danchin N; Puymirat E; Steg PG; Goldstein P; Schiele F; Belle L; Cottin Y; Fajadet J; Khalife K; Coste P; Ferrières J; Simon T;
    Circulation; 2014 Apr; 129(16):1629-36. PubMed ID: 24657993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Acute kidney injury - A frequent and serious complication after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    El-Ahmadi A; Abassi MS; Andersson HB; Engstrøm T; Clemmensen P; Helqvist S; Jørgensen E; Kelbæk H; Pedersen F; Saunamäki K; Lønborg J; Holmvang L
    PLoS One; 2020; 15(2):e0229346. PubMed ID: 32049996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial.
    Timmer JR; Ottervanger JP; de Boer MJ; Boersma E; Grines CL; Westerhout CM; Simes RJ; Granger CB; Zijlstra F;
    Arch Intern Med; 2007 Jul; 167(13):1353-9. PubMed ID: 17620527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognostic value of ST-segment resolution in patients treated with fibrinolysis or primary percutaneous coronary intervention results from the DANAMI-2 (DANish trial in acute myocardial infarction-2).
    Sejersten M; Valeur N; Grande P; Nielsen TT; Clemmensen P;
    J Am Coll Cardiol; 2009 Nov; 54(19):1763-9. PubMed ID: 19874989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of percutaneous coronary intervention after fibrinolytic therapy for ST-segment elevation acute myocardial infarction.
    Baron SJ; Giugliano RP
    Am J Cardiol; 2011 Apr; 107(7):1001-9. PubMed ID: 21256466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London.
    Iqbal MB; Ilsley C; Kabir T; Smith R; Lane R; Mason M; Clifford P; Crake T; Firoozi S; Kalra S; Knight C; Lim P; Malik IS; Mathur A; Meier P; Rakhit RD; Redwood S; Whitbread M; Bromage D; Rathod K; MacCarthy P; Dalby M;
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):936-43. PubMed ID: 25371542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
    Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
    Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reperfusion strategies in acute coronary syndromes.
    Bagai A; Dangas GD; Stone GW; Granger CB
    Circ Res; 2014 Jun; 114(12):1918-28. PubMed ID: 24902975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis.
    Borgia F; Goodman SG; Halvorsen S; Cantor WJ; Piscione F; Le May MR; Fernández-Avilés F; Sánchez PL; Dimopoulos K; Scheller B; Armstrong PW; Di Mario C
    Eur Heart J; 2010 Sep; 31(17):2156-69. PubMed ID: 20601393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized comparison of primary percutaneous coronary intervention with combined proximal embolic protection and thrombus aspiration versus primary percutaneous coronary intervention alone in ST-segment elevation myocardial infarction: the PREPARE (PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-Elevation) study.
    Haeck JD; Koch KT; Bilodeau L; Van der Schaaf RJ; Henriques JP; Vis MM; Baan J; Van der Wal AC; Piek JJ; Tijssen JG; Krucoff MW; De Winter RJ
    JACC Cardiovasc Interv; 2009 Oct; 2(10):934-43. PubMed ID: 19850252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic postconditioning during primary percutaneous coronary intervention: the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial.
    Hahn JY; Song YB; Kim EK; Yu CW; Bae JW; Chung WY; Choi SH; Choi JH; Bae JH; An KJ; Park JS; Oh JH; Kim SW; Hwang JY; Ryu JK; Park HS; Lim DS; Gwon HC
    Circulation; 2013 Oct; 128(17):1889-96. PubMed ID: 24068776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermodilution-derived coronary blood flow pattern immediately after coronary intervention as a predictor of microcirculatory damage and midterm clinical outcomes in patients with ST-segment-elevation myocardial infarction.
    Fukunaga M; Fujii K; Kawasaki D; Sawada H; Miki K; Tamaru H; Imanaka T; Iwasaku T; Nakata T; Shibuya M; Akahori H; Masutani M; Kobayashi K; Ohyanagi M; Masuyama T
    Circ Cardiovasc Interv; 2014 Apr; 7(2):149-55. PubMed ID: 24550440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
    Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of coronary microvascular function on long-term cardiac mortality in patients with acute ST-segment-elevation myocardial infarction.
    van de Hoef TP; Bax M; Meuwissen M; Damman P; Delewi R; de Winter RJ; Koch KT; Schotborgh C; Henriques JP; Tijssen JG; Piek JJ
    Circ Cardiovasc Interv; 2013 Jun; 6(3):207-15. PubMed ID: 23735476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.